Diasorin reported EUR99M in Cost of Sales for its fiscal quarter ending in September of 2024.

Cost Of Sales Change Date
Amplifon EUR 453.6M 8.98M Sep/2024
Avanos Medical USD 77.5M 4.4M Sep/2024
Brookdale Senior Living USD 586.04M 13.32M Sep/2024
Cencora USD 76.56B 4.68B Sep/2024
Diasorin EUR 99M 2M Sep/2024
Encompass Health USD 60.6M 697.5M Sep/2024
Enovis USD 218.76M 6.39M Sep/2024
GE HealthCare Technologies USD 4.86B 2.03B Sep/2024
OPKO Health USD 133.5M 21.12M Sep/2024
Zimmer Biomet Holdings USD 538.6M 15M Sep/2024